Application of water-soluble/dispersible polymeric carriers in drug dissolution modulation

Asian Journal of Pharmaceutical Sciences

Volumn 6, Issue 1, 2011, Pages 26-35

  Boregowda, Sateesha Shvally ^a   Prakash Rao, B ^a   Jayarama, Rajamma Abburu ^b   Guruchar, Nargund L V ^c  

^a ACHARYA AND B M REDDY COLLEGE OF PHARMACY   (India)

^b A Constituent Unit of KLE Academy of Higher Education Research   (India)

^c Nargund College of Pharmacy   (India)

Author keywords

Complexation; Gibbs free energy value; Glimepiride; Solid dispersion; Ternary mixture

Indexed keywords

BETA CYCLODEXTRIN; CROSCARMELLOSE SODIUM; GLIMEPIRIDE; MACROGOL 4000; MICROCRYSTALLINE CELLULOSE; POLYMER;

ANIMAL TISSUE; ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG MIXTURE; DRUG SOLUBILITY; EVAPORATION; HYDROPHOBICITY; IN VITRO STUDY; INFRARED SPECTROSCOPY; NONHUMAN; SOLID STATE; X RAY DIFFRACTION;

EID: 80054096746     PISSN: 18180876     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Grbic JP, Andjelija M, Zorica D, et al. A contribution to the glimepiride dissociantion constant determination. J Chem Eng Data. 2010, 55: 1368-1371.
2. Rosenkranz B, Profozic V, Metelko Z, et al. Pharmacokinetics and safety of glimepiride at clinically effective doses in diabetic patients with renal impairment. Diabetologia. 1996, 39: 1617-1624.
3. Bando K, Yamada Y. Glimepiride (Amaryl): a review of its pharmacological and clinical profile. Folia Pharmacol Japonica. 2001, 118: 59-67.
4. Langtry H, Balfour JA. Glimepiride: a review of its use in the management of type-2 diabetes mellitus. Drugs. 1998, 55: 563-584.
5. White JR, Campbell RK. Recent developments in the pharmacological reduction of blood glucose in patients with type 2 diabetes. Clin Diab. 2001, 19: 153-159.
6. Neelam S, Mamta K. Co-solvent solubilization of some poorly- soluble antidiabetic drugs. Pharma Dev Tech. 2009, 14, 185-192.
7. Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersion. Eur J Pharm Biopharm. 2000, 50: 47-60.
8. Sukmadjaja A, Faizatun HR. In vivo and in vitro evaluation of a solid dispersion system of gliclazide: PEG 6000. PDA J Pharma Sci Tech. 2007, 61: 400-410.
9. Law LS, Lo WY. Dissolution behaviour of griseofulvin solid dispersions using polyethylene glycol, talc, and their combination as dispersion carriers. Drug Dev Ind Pharm. 1996, 32: 231-236.
10. Ammar HO, Salama HA, Ghorab M. et al. Inclusion complexation of Glimeperide in dimethyl-β-cyclodextrin. Asian J Pharm Sci. 2007, 2: 44-55.
11. Conard S, Winters PT. Solid state examination of a Gliclazide:beta-cyclodextrin complex. Eur J Pharm Sci. 1997, 5: 209-214.
12. Ammar O, Salama HA, Ghoab M, et al. Formulation and biological evaluation of glimepiride-cyclodextrin-polymer systems. Int J Pharm. 2006, 309: 129-138.
13. Barzegar JM, Dasmatalchi S. Kinetic analysis of cholorpropamide dissolution from solid dispersions. Drug Dev Ind Pharm. 2007, 33: 63-70.
14. Beatgeri GV, Makarla KR. Enhancement of dissolution of glyburide by solid dispersion and lyophillization techniques. Int J Pharm. 1995, 126: 155-160.
15. Dissolution methods. A-Z index. FDA, US food and drug administration.
16. Moshtaghie AA, Taher M. Aluminium interference with iron absorption by everted gut sac. J Islamic Aca Sci. 1993, 6: 1016-1045.
17. Mariappan T, Saranjit S. Evidence of efflux-mediated and saturable absorption of rifampicin in rat intestine using the ligated loop and everted gut sac techniques. Mol Pharm. 2004, 1: 363-367.
18. Fischer LJ, Millburn P. Stilboestrol transport and glucoronide formation in everted sacs of rat intestine. J Pharm Exp Ther. 1970, 175: 267-275.
19. Sudarsan B, Gouri SP, Jaganath S, et al. An approach for improvement of the dissolution rate of gliclazide. Dis Tech. 2009, 11: 15-20.
20. Sateesha SB, Prakashrao B, Rajamma AJ, et al. The effect of polymers on the aqueous solubility and dissolution behaviour of glicazide-β-cyclodextrin complex. Der Pharm Let. 2010, 2: 237-248.
21. Roya T, Jaleh V, Syed AM, et al. Dissolution Enhancement of Gliclazide using pH change approach in presence of twelve stabilizers with various physico-chemical properties. J Pharm Pharm Sci. 2009, 12: 250-265.
22. Trapani G, Franco M, Latrofa A, et al. Physicochemical characterization and in vivo properties of zolpidem in solid dispersions with polyethylene glycol 4000 and 6000. Int J Pharm. 1999, 184: 121-130.
23. Mura P, Manderioli A, Bramanti G, et al. Propeties of solid dispersions of naproxen in various polyethylene glycols. Drug Dev Ind Pharm. 1996, 22: 909-916.